Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02378077 · ClinicalTrials.gov registry record · NA

Understanding the Relationship Between Inflammation and Insulin Resistance in the Adipose Tissue

A NA study, sponsored by Mayo Clinic.

Completed
Registry status
NA
Development phase
28
Enrollment target

NCT02378077: Completed NA study, sponsored by Mayo Clinic.

NCT02378077 is a NA study that has completed, run by Mayo Clinic. The registered enrollment target is 28 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist → Add completion date to calendar (.ics) →

The verdict

NCT02378077, a NA study, has completed, sponsored by Mayo Clinic.

COMPLETED
Registry status
NA
Development phase
28 participants
Enrollment target

Study Summary

This study is being done to better understand the relationship between inflammation and insulin resistance in your Adipose (fat) Tissue .

Primary Outcome

Eosinophils number will be measured by flow cytometry in subcutaneous and visceral fat of lean vs obese, non-diabetic volunteers

Interventions

  • PROCEDURE Fat biopsy during scheduled abdominal surgery
  • PROCEDURE Fat Aspiration
  • DIETARY_SUPPLEMENT Fish Oil Supplement

Trial Details

FieldValue
Enrollment Target 28 participants
Start Date 2014-08
Est. Completion 2018-10
Phase NA
Mayo Clinic

2,844 total trials

What the finished NCT02378077 record still lists

NCT02378077 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 28 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower).

The record links to 0 conditions, and to 3 interventions - of which Fat biopsy during scheduled abdominal surgery is the first listed.

NCT02378077 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT02378077 about?

NCT02378077 is a clinical study titled "Understanding the Relationship Between Inflammation and Insulin Resistance in the Adipose Tissue". This study is being done to better understand the relationship between inflammation and insulin resistance in your Adipose (fat) Tissue .

What is the current status of trial NCT02378077?

This trial is currently completed. It is a NA study. The enrollment target is 28 participants. The study started on 2014-08. Estimated completion is 2018-10.

What interventions are being tested in trial NCT02378077?

The interventions under investigation include: Fat biopsy during scheduled abdominal surgery (PROCEDURE), Fat Aspiration (PROCEDURE), Fish Oil Supplement (DIETARY_SUPPLEMENT).

Who is sponsoring clinical trial NCT02378077?

This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT02378077's enrollment target sits among peer trials

28 1704th of 2000 higher than 293 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT03471117 · 28 participants · Phase 4

    Pioglitazone to Reduce Sympathetic Overactivity in CKD Patients

  • NCT03523975 · 28 participants · Phase 1

    Venetoclax, Lenalidomide and Rituximab in Patients With Previously Untreated Mantle Cell Lymphoma

  • NCT03608631 · 28 participants · Phase 1

    iExosomes in Treating Participants With Metastatic Pancreas Cancer With KrasG12D Mutation

  • NCT03810651 · 28 participants · Early Phase 1

    Pencil Beam Scanning in Patients With Renal Tumors

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT02378077, the US trial registry maintained by the National Library of Medicine. NCT02378077 (small enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.